What is Jefferies's price target for AZN?

Jefferies's latest stated price target for AstraZeneca PLC (AZN) is $70, from its action on Jan 3, 2024.

What is Jefferies's rating on AZN?

Jefferies rates AZN Buy, a bullish rating, as of Oct 27, 2025.

When did Jefferies last change its view on AZN?

On Oct 27, 2025, Jefferies resumes coverage at Buy.

Jefferies AZN price target and rating history

Jefferies rates AstraZeneca PLC (AZN) Buy with a $70 price target, as of its latest action on Oct 27, 2025. It has published 4 rating actions on AZN since December 2021, including 1 upgrade and 2 downgrades.

Current rating: Buy
Price target: $70
Median target, all firms: Too few
Actions on AZN: 4

Jefferies price target on AZN

Jefferies price target on AZN, each point a stated target, September 2023 to January 2024.

Every Jefferies rating on AZN

Oct 27, 2025
ResumeJefferies resumes coverage at Buy
Jan 3, 2024
DowngradeJefferies downgrades to Hold from Buy, price target $78.50 to $70
Sep 25, 2023
UpgradeJefferies upgrades to Buy from Hold, price target $66.50 to $80
Dec 7, 2021
DowngradeJefferies downgrades to Hold from Buy

How other firms rate AZN

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Date
Deutsche Bank	Hold	Sep 15, 2026
RBC Capital Markets	Outperform	Sep 9, 2026
HSBC	Hold	Jul 13, 2026
Citigroup	Buy	Jan 27, 2026

Questions about Jefferies and AZN

What is Jefferies's price target for AZN?: Jefferies's latest stated price target for AstraZeneca PLC (AZN) is $70, from its action on Jan 3, 2024.
What is Jefferies's rating on AZN?: Jefferies rates AZN Buy, a bullish rating, as of Oct 27, 2025.
When did Jefferies last change its view on AZN?: On Oct 27, 2025, Jefferies resumes coverage at Buy.

More AZN rating histories

All Jefferies ratings AZN news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.